SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-18-018503
Filing Date
2018-08-01
Accepted
2018-08-01 16:46:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B5 kalv-424b5.htm 424B5 684834
  Complete submission text file 0001564590-18-018503.txt   686160
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 424B5 | Act: 33 | File No.: 333-217009 | Film No.: 18985386
SIC: 2834 Pharmaceutical Preparations